Streetbeat News

Stock Prices

PETQ

Trading for PETQ was halted at 7:55:00 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:55 am

CART

Maplebear shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 adjusted EBITDA guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:54 am

EXEL

Exelixis shares are trading higher after the company reported better-than-expected Q2 results and issued FY24 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:53 am

INVZ

Innoviz Technologies has provided a revenue forecast for Q3, expecting between $3.5 million and $5 million, which is below the estimated $4.6 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:48 am

ALTM

Arcadium Lithium shares are trading higher after the company reported better-than-expected Q2 financial results and announced it expects its cost savings at the higher end of its guidance range.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:47 am

INVZ

Innoviz Technologies (NASDAQ:INVZ) reported Q2 2024 GAAP EPS of $(0.31), missing the $(0.15) estimate by 106.67%. However, sales of $6.664M beat the $4.600M estimate by 44.87%, marking a 354.57% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:46 am

CRUS

Cirrus Logic shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:45 am

SHO

Sunstone Hotel Investors has narrowed its FY24 adjusted FFO per share outlook from $0.84 - $0.94 to $0.85 - $0.90, with an estimate of $0.90.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:45 am

TSVT

2seventy bio (NASDAQ:TSVT) reported Q2 2024 adjusted EPS of $(0.29), beating the estimate of $(0.65). However, sales of $8.967M missed the $14.195M estimate and were down 75.12% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:45 am

ACAD

ACADIA Pharmaceuticals shares are trading lower after the company reported Q2 financial results. Morgan Stanley downgraded the stock to Equal-Weight following the report.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:44 am